Oxford vaccine shows 90% efficacy in Phase-3 trial
Two doses of the vaccine given in two different regimen showed different efficacies. In the case of the regimen (involving 2,741 participants) where a halved dose was used as a…
Category: Communicable disease
Ethics of denying COVID-19 vaccine to placebo group participants once EUA is granted
Offering the vaccine right away to those in the placebo group will first require unblinding the study. Unblinding the study and offering the vaccine to the placebo group will make it almost impossible to gather further information on vaccine efficacy, thus making full licensure challenging.
Oxford vaccine found safe and immunogenic even in older adults
The results were published online in The Lancet on November 19. The results are based on the study of 560 participants enrolled between May 30 and August 8. Of the…
Pfizer’s mRNA vaccine 95% efficacious, final analysis shows
On November 18, Pfizer announced that the final efficacy analysis of its candidate mRNA-based vaccine (BNT162b2) in phase-3 trial has been completed and the vaccine shows 95% efficacy to prevent…
More mRNA COVID-19 vaccines show stability at higher temperatures
The interim results of Moderna’s mRNA vaccine show that the vaccine has 94.5% efficacy in preventing COVID-19. The interim analysis, which was based on 95 cases, found that 90 participants…
Pfizer’s COVID-19 vaccine shows promise, many unknowns remain
The results of the Phase-1 trial, announced in August, first through a press release and then through a preprint a week later, showed that the vaccine induced neutralising antibodies and…
Eight Indian generic drug companies join international coalition, pledge to make COVID-19 drugs
The companies have come together under the umbrella of the non-profit Medicines Patent Pool (MPP). Indian companies that have pledged to manufacture COVID-19 drugs include Sun Pharma, Lupin, Aurobindo, Zydus Cadila,…
It makes sense to bring people to the vaccine instead of taking COVID-19 vaccine to people in some settings: Gagandeep Kang
Government has prioritised certain groups to receive the vaccine first. Which vulnerable groups do you think should receive the vaccine on priority? Frontline healthcare workers at every level should receive vaccines when…
